Martin Ivanovski
About
In The Last Decade
Martin Ivanovski
15 papers receiving 390 citations
Peers
Comparison fields: 5 of 36
- Genetics 234
- Pathology and Forensic Medicine 155
- Hepatology 142
- Immunology 128
- Epidemiology 68
Countries citing papers authored by Martin Ivanovski
This map shows the geographic impact of Martin Ivanovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ivanovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ivanovski more than expected).
Fields of papers citing papers by Martin Ivanovski
This network shows the impact of papers produced by Martin Ivanovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ivanovski. The network helps show where Martin Ivanovski may publish in the future.
Co-authorship network of co-authors of Martin Ivanovski
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Ivanovski. A scholar is included among the top collaborators of Martin Ivanovski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Ivanovski. Martin Ivanovski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | Multivariable model consisting of clinical and biological markers for time to first treatment in CLL patients: Preliminary results from single centre experience. | 2 |
| 10 | Minimal screening analysis based algorithm for diagnosis and clinical stratification of patients with acute myeloid leukaemia (AML): single centre experience. | 0 |
| 11 | 1 | |
| 12 | JAK2V617F mutations in myeloid malignancies: single center experience. | 0 |
| 13 | 8 | |
| 14 | Pentoxifylline--efficient in the treatment of venous ulcers in the absence of compression? | 12 |
| 15 | 8 | |
| 16 | 21 | |
| 17 | 212 | |
| 18 | 4 | |
| 19 | 47 | |
| 20 | 61 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.